A Framework for Assessing Immunological Correlates of Protection in Vaccine Trials
- 1 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (9) , 1304-1312
- https://doi.org/10.1086/522428
Abstract
A central goal of vaccine research is to identify a vaccine-induced immune response that predicts protection from infection or disease. The term "correlate of protection" has been used to refer to at least 3 distinct concepts, which has resulted in confusion surrounding this topic. We propose precise definitions of these different concepts of immune correlates, using the nomenclature "correlate of risk," "level 1 surrogate of protection," and "level 2 surrogate of protection." We suggest a general framework for assessing these 3 levels of immune correlates in vaccine efficacy trials. To demonstrate the proposed principles, we analyze data from a 1943 influenza vaccine field trial, supporting Weiss strain A—specific antibody titers as a level 1 surrogate of protection. Other real and simulated examples are also discussed.Keywords
This publication has 0 references indexed in Scilit: